SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950133-98-001860
Filing Date
1998-05-13
Accepted
1998-05-13 00:00:00
Documents
6
Period of Report
1998-03-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 GUILFORD PHARMACEUTICALS INC. FORM 10-Q 10-Q 65405
2 MASTER LEASE AGREEMENT EX-10.50 38601
3 EMPLOYMENT AGREEMENT RE: GREGORY D. HOCKEL, PH.D. EX-10.57 9323
4 EMPLOYMENT AGREEMENT RE: DANA HILT, M.D. EX-10.58 11690
5 COMPUTATION OF EARNINGS (LOSS) PER SHARE EX-11.2 1971
6 FINANCIAL DATA SCHEDULE EX-27.2 2216
  Complete submission text file 0000950133-98-001860.txt   131115
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23736 | Film No.: 98618991
SIC: 2834 Pharmaceutical Preparations